7Baggers

Adlai Nortye Ltd.
(NASDAQ:ANL) 

ANL stock logo

Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent ...

Founded: 2004
IPO Price: $23 (Sep 29, 2023)
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends